Global Injectable Anticoagulants Sales Market Size Growing at a CAGR of 2.8% during 2018-2025

Posted on 2018-06-22 by Mark Hub in Pharmaceuticals // 0 Comments

Albany, US, June 22, 2018: Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Injectable Anticoagulants Sales Market” Report 2018 provides an in-depth analysis of the Injectable Anticoagulants with the forecast of market size and growth. The analysis includes addressable market, market by volume, and market share by business type and by segment (external and in-house).The research study examines the Injectable Anticoagulants on the basis of a number of criteria, such as the product type, application, and its geographical presence.

The whole supply chain of Injectable Anticoagulants has been explained with statistical details with a special emphasis on various upstream and downstream components. The current trends pertaining to the demand, supply, and sales of Injectable Anticoagulants, together with the recent developments have been given here to provide an exhaustive picture of this market.

Click here for Free Sample Report@ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1837404

This report studies the global Injectable Anticoagulants market status and forecast, categorizes the global Injectable Anticoagulants market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin], enoxaparin [Lovenox]) and factor Xa inhibitors (fondaparinux [Arixtra]).
In the last several years, global market of injectable anticoagulants developed slowly. In 2016, global revenue of injectable anticoagulants is nearly 5300 M USD. And the global growth rate is slow.
The classification of injectable anticoagulants includes LMWH, DTI and other, and the proportion of LMWH in 2016 is about 55%, and the proportion is in decreasing trend from 2012 to 2016.
Injectable anticoagulants are widely used for VTE, ACS/MI, AF and other field. The most proportion of injectable anticoagulants used to treat AF, and the revenue in 2016 is 3400 M USD.
The global Injectable Anticoagulants market is valued at 5490 million US$ in 2017 and will reach 6820 million US$ by the end of 2025, growing at a CAGR of 2.8% during 2018-2025.

The major players covered in this report
Sanofi
Genentech (Roche)
Boehringer Ingelheim
Pfizer
The Medicines Company
Aspen
Otsuka
…

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Low-molecular-weight Heparin (LMWH)
Direct Thrombin Inhibitor (DTI)
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
VTE
ACS/MI
AF
Other

Browse Full Report with TOC@ https://www.marketresearchhub.com/report/global-injectable-anticoagulants-sales-market-report-2018-report.html

Table of Contents

Global Injectable Anticoagulants Sales Market Report 2018
1 Injectable Anticoagulants Market Overview
1.1 Product Overview and Scope of Injectable Anticoagulants
1.2 Classification of Injectable Anticoagulants by Product Category
1.2.1 Global Injectable Anticoagulants Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Injectable Anticoagulants Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Low-molecular-weight Heparin (LMWH)
1.2.4 Direct Thrombin Inhibitor (DTI)
1.2.5 Other
1.3 Global Injectable Anticoagulants Market by Application/End Users
1.3.1 Global Injectable Anticoagulants Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.1 VTE
1.3.2 ACS/MI
1.3.3 AF
1.3.4 Other
1.4 Global Injectable Anticoagulants Market by Region
1.4.1 Global Injectable Anticoagulants Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Injectable Anticoagulants Status and Prospect (2013-2025)
1.4.3 Europe Injectable Anticoagulants Status and Prospect (2013-2025)
1.4.4 China Injectable Anticoagulants Status and Prospect (2013-2025)
1.4.5 Japan Injectable Anticoagulants Status and Prospect (2013-2025)
1.4.6 Southeast Asia Injectable Anticoagulants Status and Prospect (2013-2025)
1.4.7 India Injectable Anticoagulants Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Injectable Anticoagulants (2013-2025)
1.5.1 Global Injectable Anticoagulants Sales and Growth Rate (2013-2025)
1.5.2 Global Injectable Anticoagulants Revenue and Growth Rate (2013-2025)

2 Global Injectable Anticoagulants Competition by Players/Suppliers, Type and Application
2.1 Global Injectable Anticoagulants Market Competition by Players/Suppliers
2.1.1 Global Injectable Anticoagulants Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Injectable Anticoagulants Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Injectable Anticoagulants (Volume and Value) by Type
2.2.1 Global Injectable Anticoagulants Sales and Market Share by Type (2013-2018)
2.2.2 Global Injectable Anticoagulants Revenue and Market Share by Type (2013-2018)
2.3 Global Injectable Anticoagulants (Volume and Value) by Region
2.3.1 Global Injectable Anticoagulants Sales and Market Share by Region (2013-2018)
2.3.2 Global Injectable Anticoagulants Revenue and Market Share by Region (2013-2018)
2.4 Global Injectable Anticoagulants (Volume) by Application

3 United States Injectable Anticoagulants (Volume, Value and Sales Price)
3.1 United States Injectable Anticoagulants Sales and Value (2013-2018)
3.1.1 United States Injectable Anticoagulants Sales and Growth Rate (2013-2018)
3.1.2 United States Injectable Anticoagulants Revenue and Growth Rate (2013-2018)
3.1.3 United States Injectable Anticoagulants Sales Price Trend (2013-2018)
3.2 United States Injectable Anticoagulants Sales Volume and Market Share by Players (2013-2018)
3.3 United States Injectable Anticoagulants Sales Volume and Market Share by Type (2013-2018)
3.4 United States Injectable Anticoagulants Sales Volume and Market Share by Application (2013-2018)

Continued…..@@

Enquire about this Report@ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1837404

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like pharmaceutical market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Matched content

Editor’s pick